Hematology, Transfusion and Cell Therapy (Apr 2023)

Bloodstream infection in pediatric patients with febrile neutropenia induced by chemotherapy

  • Mariana Antunes Faria Lima,
  • Karla Emília de Sá Rodrigues,
  • Michelle Fonseca Vanucci,
  • Paula Larissa Lebron da Silva,
  • Thais Baeta,
  • Iara Paiva Oliveira,
  • Roberta Maia de Castro Romanelli

Journal volume & issue
Vol. 45, no. 2
pp. 170 – 175

Abstract

Read online

Introduction: Febrile neutropenia (FN) is a serious complication of cancer chemotherapy. The present study aimed to identify risk factors for documented infection in pediatric patients with FN and cancer. Methods: This prospective cohort study included patients under 18 years from 2016 to 2018. Infection was defined according to the Centers for Disease Control and Prevention criteria. Results: A total of 172 febrile neutropenic episodes were evaluated. From univariate analysis, the risk factors were: female gender; monocyte count 90 mg/dl and hemoglobin 90mg/dl, fever onset and first blood culture with a positive result. The lowest probability of infection was related to first episode and to platelets > 50,000 at the onset of fever. Conclusion: A CRP > 90 at the onset of a febrile episode, platelets < 50,000, second episode or more, first fever episode during hospitalization and positive first blood culture were found to be associated with a higher risk of infection and they could be useful for the establishment of risk scores for infection in neutropenic children.

Keywords